Novel Integration of New prostate radiation therapy schedules with adJuvant Androgen deprivation

In men with intermediate and high-risk prostate cancer, the NINJA trial is looking at comparing two different radiotherapy treatment schedules called stereotactic body radiotherapy (SBRT). The aim is to develop better methods of treatment for prostate cancer using this type of treatment, and further understand what causes some of the side effects of treatments. It is hoped this research will potentially improve the accuracy and quality of radiotherapy treatment in prostate cancer.

Primary Sponsor

Trans Tasman Radiation Oncology Group (TROG)

Collaborating Groups

Australian and New Zealand Urogenital and Prostate Cancer Trials Group (ANZUP)

Accrual Target

472

Final Accrual

472

Closing Date of Accrual

14 July 2026

Trial Chairperson

Prof Jarad Martin, Calvary Mater Hospital, NSW, Australia

Dr Mark Sidhom, Liverpool Hospital, NSW, Australia

Trial Contact

chc-calvarymater-ninjatrial@health.nsw.gov.au

Clinical Trial Registration

Related Post

26 September, 2026

Trial finds radiation therapy halves risk of brain tumour recurrence after surgery

LATEST NEWS: 26 September 2026 Giving radiotherapy after surgery

17 September, 2026

Meet the TROG Quality Assurance team

TROG UPDATES: 17 September 2026 Our Quality Assurance team